{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:23Z","timestamp":1778679083727,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1208"],"award-info":[{"award-number":["CRC 1208"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.neuint.2022.105422","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T23:20:38Z","timestamp":1665789638000},"page":"105422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development of an \u03b1-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy"],"prefix":"10.1016","volume":"161","author":[{"given":"Marc","family":"Sevenich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Honold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Willuweit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Kutzsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine","family":"Mohrl\u00fcder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Willbold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuint.2022.105422_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"alpha-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neuint.2022.105422_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archneurol.2010.194","article-title":"Frequency of known mutations in early-onset Parkinson disease","volume":"67","author":"Alcalay","year":"2010","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2022.105422_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5603\/PJNNS.a2019.0013","article-title":"Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis","volume":"53","author":"Barc","year":"2019","journal-title":"Neurol. Neurochir. Pol."},{"issue":"6","key":"10.1016\/j.neuint.2022.105422_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neuint.2022.105422_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41531-022-00330-x","article-title":"Quantitative detection of alpha-Synuclein and Tau oligomers and other aggregates by digital single particle counting","volume":"8","author":"Blomeke","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"9440","key":"10.1016\/j.neuint.2022.105422_bib6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neuint.2022.105422_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0","article-title":"A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease","volume":"59","author":"Giasson","year":"2000","journal-title":"J. Neurosci. Res."},{"issue":"8","key":"10.1016\/j.neuint.2022.105422_bib8","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1073\/pnas.1013225108","article-title":"Low-resolution structure of a vesicle disrupting alpha-synuclein oligomer that accumulates during fibrillation","volume":"108","author":"Giehm","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"44","key":"10.1016\/j.neuint.2022.105422_bib9","doi-asserted-by":"crossref","first-page":"15871","DOI":"10.1073\/pnas.0506109102","article-title":"Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR","volume":"102","author":"Heise","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4\u20135","key":"10.1016\/j.neuint.2022.105422_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clinbiochem.2016.11.001","article-title":"sFIDA automation yields sub-femtomolar limit of detection for Abeta aggregates in body fluids","volume":"50","author":"Herrmann","year":"2017","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.neuint.2022.105422_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","article-title":"Dependence of alpha-synuclein aggregate morphology on solution conditions","volume":"322","author":"Hoyer","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.neuint.2022.105422_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","article-title":"Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update","volume":"119","author":"Jellinger","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.neuint.2022.105422_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015801","article-title":"Targeted amino-terminal acetylation of recombinant proteins in E. coli","volume":"5","author":"Johnson","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuint.2022.105422_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1750-3639.2008.00140.x","article-title":"Three-layered structure shared between Lewy bodies and Lewy neurites - three-dimensional reconstruction of triple-labeled sections","volume":"18","author":"Kanazawa","year":"2008","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.neuint.2022.105422_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020157","article-title":"Inhibition of polyglutamine misfolding with D-enantiomeric peptides identified by mirror image phage display selection","volume":"12","author":"Kolkwitz","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neuint.2022.105422_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bioinformatics\/btv522","article-title":"Hammock: a hidden Markov model-based peptide clustering algorithm to identify protein-interaction consensus motifs in large datasets","volume":"32","author":"Krejci","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuint.2022.105422_bib17","first-page":"146","author":"Kumar","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.neuint.2022.105422_bib18","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1021\/ja411577t","article-title":"The role of stable alpha-synuclein oligomers in the molecular events underlying amyloid formation","volume":"136","author":"Lorenzen","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.neuint.2022.105422_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.semnuclmed.2017.06.003","article-title":"Small-molecule PET tracers for imaging proteinopathies","volume":"47","author":"Mathis","year":"2017","journal-title":"Semin. Nucl. Med."},{"issue":"7","key":"10.1016\/j.neuint.2022.105422_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.neuint.2022.105422_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.25373","article-title":"Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?","volume":"28","author":"Olanow","year":"2013","journal-title":"Mov. Disord."},{"issue":"1\u20133","key":"10.1016\/j.neuint.2022.105422_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the cns of patients with multiple system Atrophy (Striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager Syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"issue":"7706","key":"10.1016\/j.neuint.2022.105422_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105422_bib24","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"13","key":"10.1016\/j.neuint.2022.105422_bib25","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1021\/acschemneuro.1c00253","article-title":"Ligand-induced Stabilization of the native human Superoxide Dismutase 1","volume":"12","author":"Santur","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2022.105422_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020441","article-title":"Phage display-derived compounds Displace hACE2 from its complex with SARS-CoV-2 Spike protein","volume":"10","author":"Sevenich","year":"2022","journal-title":"Biomedicines"},{"issue":"6645","key":"10.1016\/j.neuint.2022.105422_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"6645","key":"10.1016\/j.neuint.2022.105422_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuint.2022.105422_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuint.2022.105422_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12951-017-0269-2","article-title":"A retro-inverso cell-penetrating peptide for siRNA delivery","volume":"15","author":"Vaissiere","year":"2017","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.neuint.2022.105422_bib32","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.neuint.2022.105422_bib33","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson's disease and multiple system atrophy have distinct alpha-synuclein seed characteristics","volume":"294","author":"Yamasaki","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuint.2022.105422_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1695","article-title":"Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases","volume":"13","author":"Zhou","year":"2021","journal-title":"Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622001474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622001474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:47:38Z","timestamp":1778676458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018622001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"alternative-id":["S0197018622001474"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105422","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an \u03b1-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105422"}}